GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (XKAZ:JNJ_KZ) » Definitions » Institutional Ownership

Johnson & Johnson (XKAZ:JNJ_KZ) Institutional Ownership : 41.39% (As of Apr. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Johnson & Johnson Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Johnson & Johnson's institutional ownership is 41.39%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Johnson & Johnson's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Johnson & Johnson's Float Percentage Of Total Shares Outstanding is 99.96%.


Johnson & Johnson Institutional Ownership Historical Data

The historical data trend for Johnson & Johnson's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Institutional Ownership Chart

Johnson & Johnson Historical Data

The historical data trend for Johnson & Johnson can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 45.45 45.42 46.45 44.95 41.26 41.45 41.75 41.76 41.76 41.39

Johnson & Johnson Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Johnson & Johnson (XKAZ:JNJ_KZ) Business Description

Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.

Johnson & Johnson (XKAZ:JNJ_KZ) Headlines

No Headlines